Genix Pharmaceuticals Corp. Receives Approval for Drug Establishment LicenseJuly 15, 2021Vancouver, British Columbia, July 15th, 2021 – Genix Pharmaceuticals Corporation (TSX-V:…
Genix Pharmaceuticals Corp. Lists on the OTCQB Venture Market ExchangeJune 21, 2021Vancouver, British Columbia, June 21st, 2021 – Genix Pharmaceuticals Corporation…
Genix Pharmaceuticals Corporation Provides a Corporate Update To ShareholdersJune 7, 2021VANCOUVER, June 07, 2021 – Genix Pharmaceuticals Corporation (TSXV: GENX)…
Genix Pharmaceuticals Corp. Announces AGM Results and Appoints Mahmoud Aziz to the Board and as PresidentMay 20, 2021Vancouver, British Columbia, May 20, 2021 — Genix Pharmaceuticals Corporation (TSX-V:…
Genix Pharmaceuticals Corporation Enters into Exclusive License and Supply Agreement for Canada’s First Generic Thyroid MedicationApril 1, 2021Vancouver, British Columbia, April 1, 2021 – Genix Pharmaceuticals Corporation…
Genix Pharmaceuticals Corporation prepares to file Abbreviated New Drug Submissions (ANDS) for its first ten Ophthalmic Drugs with Health CanadaMarch 22, 2021Genix Introduces Paul Chow to the Board of Directors Vancouver,…